Financhill
Back

Accolade 10K Form

Sell
34

ACCD
Accolade

Last Price:
3.72
Seasonality Move:
28.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACCD News And Ratings

See the #1 stock for the next 7 days that we like better than ACCD

ACCD Financial Statistics

Sales & Book Value

Annual Sales: $414.29M
Cash Flow: $3.1M
Price / Cash Flow: 0
Annual Sales: $5.26
Price / Book: 0.68

Profitability

EPS (TTM): -1.03000
Net Income (TTM): $-80.1M
Gross Margin: $192.06M
Return on Equity: -18.4%
Return on Assets: -10.14%

Accolade Earnings Forecast

Key Accolade Financial Ratios

  • The Gross Profit Margin over the past 7 years for ACCD is 46.36%.
  • The Selling, General & Administrative Expenses for ACCD have been equal to 39.15% of Gross Profit Margin.
  • The Research & Development expenses have been 23.93% of Revenue.
  • The Interest Expense is -2.36% of Operating Income.
  • The Net Earning history of ACCD is -24.09% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Accolade Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ACCD
CUSIP: 00437E
Website: accolade.com

Debt

Debt-to-Equity Ratio: 0.49
Current Ratio: 2.72
Quick Ratio: 2.57

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACCD Technical Analysis vs Fundamental Analysis

Sell
34
Accolade (ACCD) is a Sell

Is Accolade a Buy or a Sell?

  • Accolade stock is rated a Sell
    The current Accolade [ACCD] share price is $3.56. The Score for ACCD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.